Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001387131-19-002797
Filing Date
2019-04-22
Accepted
2019-04-22 15:50:56
Documents
49
Period of Report
2018-02-28

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT plsi-10k_022818.htm 10-K 775853
2 CERTIFICATION OF CHIEF EXECUTIVE OFFICER ex31-1.htm EX-31.1 9813
3 CERTIFICATION OF CHIEF FINANCIAL OFFICER ex31-2.htm EX-31.2 9808
4 CERTIFICATION OF CHIEF EXECUTIVE OFFICER ex32-1.htm EX-32.1 4539
5 CERTIFICATION OF CHIEF FINANCIAL OFFICER ex32-2.htm EX-32.2 4618
12 GRAPHIC plsi001.jpg GRAPHIC 3806
13 GRAPHIC plsi002.jpg GRAPHIC 1272
  Complete submission text file 0001387131-19-002797.txt   2686568

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT plsi-20180228.xml EX-101.INS 275313
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT plsi-20180228.xsd EX-101.SCH 31520
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT plsi-20180228_cal.xml EX-101.CAL 33910
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT plsi-20180228_def.xml EX-101.DEF 139538
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT plsi-20180228_lab.xml EX-101.LAB 231166
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT plsi-20180228_pre.xml EX-101.PRE 182165
Mailing Address 3000 LAWRENCE STREET DENVER CO 80205
Business Address 3000 LAWRENCE STREET DENVER CO 80205 1.720.699.7222
Phoenix Life Sciences International Limited. (Filer) CIK: 0001493212 (see all company filings)

EIN.: 460525378 | State of Incorp.: NV | Fiscal Year End: 0228
Type: 10-K | Act: 34 | File No.: 333-167275 | Film No.: 19759435
SIC: 1311 Crude Petroleum & Natural Gas